Description

Global Fetal Bovine Serum Market: by Type (Charcoal Stripped, Chromatographic, Exosome Depleted, Stem Cell, and Others), by Application (Drug Discovery, Cell Culture Media, In Vitro Fertilization, Diagnostics, and Others), by End User (Pharmaceutical, Research & Academic Institutes, and Others) and by Region – Global Industry Sizing, Growth, Trend, Opportunity, and Forecast (2021–2027)

The fetal bovine serum market report covers a thorough analysis of the market dynamics, business models, segmental/regional analysis, and respective market shares and strategies adopted by the key market players operating globally. It entails an in-depth analysis of the factors influencing the global market and market statistics indicating region-wise and segment-wise market share/growth analysis. The report's study will outlook one of the most exhaustive market analyses, capturing all the fetal bovine serum industry aspects.

Fetal Bovine Serum Industry Outlook

The global fetal bovine serum market size was valued at USD 812 million in 2020, which is expected to reach USD 1,226 billion by 2027, registering a CAGR of 5.8% during the forecast period (2021-2027). Fetal bovine serum is a by-product obtained from a bovine fetus produced in the meat processing industries. It is an effective growth promoter used as a supplement due to its high nutritional and macromolecular factors. The trend for fetal bovine serum is increasing with the advancement in biotechnology and diagnostic industries.

Factors Affecting the Fetal Bovine Serum Industry over the Forecast Period:

Factors such as an increase in R&D activities for the introduction of novel biopharmaceuticals, growing investment and expenditure for research interventions in the developing nations, and rise in demand for fetal serum from the traditional users are anticipated to drive the growth of the global fetal bovine serum market.

The government is providing financial aids and taking initiatives towards the development and promotion of fetal bovine serum for health concerns which has positively impacted the sales of fetal bovine serum in the healthcare and pharmaceutical sector across the globe significantly.

However, the high price of fetal bovine serum and the availability of better alternatives will restrain the growth of fetal bovine serum in the global market over the forecast period.

Impact of COVID-19 on Fetal Bovine Serum Market:

The COVID-19 pandemic has positively impacted the growth of the fetal bovine serum market across the globe. The fetal bovine serum has found its application in preparing the viral transport medium of the COVID-19 samples. The resurgence of COVID-19 cases in developed and emerging economies, such as Turkey and Germany, will further increase the demand and market value of fetal bovine serum in 2020 and the subsequent years.

Scope of the Report

The report outlines the global fetal bovine serum market study based on type, application, and end user.

The fetal bovine serum market has been segmented based on type –

• Charcoal Stripped
• Chromatographic
• Exosome Depleted
• Stem Cell
• Others

The fetal bovine serum market has been segmented based on application –

• Drug Discovery
• Cell Culture Media
• In Vitro Fertilization
• Diagnostics
• Others

The fetal bovine serum market has been segmented based on the end user –

• Pharmaceutical
• Research & Academic Institutes
• Others

Fetal Bovine Serum Market: Regional Outlook

Based on the region, the global fetal bovine serum market has been segmented into five geographical regions, namely, North America, Asia Pacific, Europe, South America, and the Middle East and Africa. In 2019, North America held the largest share in the fetal bovine serum market, followed by the Asia Pacific and Europe due to growing awareness about fetal serum among healthcare professionals and increased research funding in the region. Moreover, Asia Pacific is expected to project the highest CAGR globally over the forecast period, owing to the region's increasing outsourcing of research activities and infrastructural development.

Fetal Bovine Serum Market Key Competitors Includes –

The fetal bovine serum market is highly fragmented, with a large number of small players across the globe. The key fetal bovine serum market manufacturers operating in the global market are –

• Access Biologics
• Animal Technologies
• Atlanta Biologics Inc.
• Bio-Techne
• Bovogen Biologics Ltd
• Corning Incorporated
• GE Healthcare
• HiMedia Laboratories
• Merck KGaA
• Nucleus Biologics
• PAN-Biotech
• Rocky Mountain Biologics
• TCS Biosciences Ltd
• Thermo Fisher Scientific Inc.
• Tissue Culture Biologics

The fetal bovine serum market report thoroughly analyzes macro-economic factors and every segment's market attractiveness. The report will include an in-depth qualitative and quantitative assessment of the segmental/regional outlook with the market players' presence in the respective segment and region/country. The information concluded in the report includes the inputs.

Fetal Bovine Serum Market Report Covers Comprehensive Analysis On:

• Market Segmentation & Regional Analysis
• Market Size of 10 years
• Pricing Analysis
• Supply & Demand Analysis
• Product Life Cycle Analysis
• Porter's Five Forces & Value Chain Analysis
• Developed & Emerging Economies Analysis
• PEST Analysis
• Market and Forecast Factor Analysis
• Market Opportunities, Risks, & Trends
• Conclusion & Recommendation
• Regulatory Landscape
• Patent Analysis
• Competition Landscape
• 15+ Company Profiles

Fetal Bovine Serum Market Regional Analysis Includes:

• North America (US, Canada, Mexico)
• South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
• Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
• Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
• The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA

Fetal Bovine Serum Market: Target Audience

• Fetal bovine serum manufacturers
• Biopharmaceutical companies
• Investors and trade experts
• Large, medium, and small-sized enterprises
• Hospitals and clinics
• Trade publications and magazines
• Government authorities, associations, and organizations

Key Issues Addressed

• What is the market size by various segmentation of the fetal bovine serum by region and its respective countries?
• What are the customer buying behavior, key takeaways, and Porter's 5 fetal bovine serum market forces?
• What are the key opportunities and trends for manufacturers involved in the fetal bovine serum supply chain?
• What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
• What and how regulations, schemes, patents, and policies are impacting the growth of the market?
• What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology?
• What will be the impact of cutting-edge technology on the fetal bovine serum market?
• How has COVID-19 impacted the demand and sales of fetal bovine serum in the global market? Also, the expected BPS drop or rise count of the market and market expected recovery period.
• Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of 25+ leading and prominent companies in the market.